Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab

Neurology. 2011 Aug 2;77(5):505-7. doi: 10.1212/WNL.0b013e318227b23f. Epub 2011 Jul 20.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Immunologic Factors / therapeutic use*
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Purpura, Thrombocytopenic, Idiopathic / complications
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Immunologic Factors
  • Natalizumab